annual EBITDA:
-$264.43M+$214.23M(+44.76%)Summary
- As of today (June 29, 2025), IBRX annual EBITDA is -$264.43 million, with the most recent change of +$214.23 million (+44.76%) on December 31, 2024.
- During the last 3 years, IBRX annual EBITDA has risen by +$56.32 million (+17.56%).
- IBRX annual EBITDA is now -88.48% below its all-time high of -$140.30 million, reached on December 31, 2019.
Performance
IBRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$97.21M-$57.09M(-142.29%)Summary
- As of today (June 29, 2025), IBRX quarterly EBITDA is -$97.21 million, with the most recent change of -$57.09 million (-142.29%) on March 31, 2025.
- Over the past year, IBRX quarterly EBITDA has increased by +$431.00 thousand (+0.44%).
- IBRX quarterly EBITDA is now -203.21% below its all-time high of -$32.06 million, reached on March 31, 2020.
Performance
IBRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$269.55M+$431.00K(+0.16%)Summary
- As of today (June 29, 2025), IBRX TTM EBITDA is -$269.55 million, with the most recent change of +$431.00 thousand (+0.16%) on March 31, 2025.
- Over the past year, IBRX TTM EBITDA has increased by +$224.66 million (+45.46%).
- IBRX TTM EBITDA is now -740.80% below its all-time high of -$32.06 million, reached on March 31, 2020.
Performance
IBRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IBRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.8% | +0.4% | +45.5% |
| 3 y3 years | +17.6% | -7.5% | +20.0% |
| 5 y5 years | -88.5% | -203.2% | -740.8% |
IBRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.8% | -142.3% | +59.4% | at high | +45.5% |
| 5 y | 5-year | -88.5% | +44.8% | -203.2% | +59.4% | -740.8% | +45.5% |
| alltime | all time | -88.5% | +44.8% | -203.2% | +59.4% | -740.8% | +45.5% |
IBRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$97.21M(+142.3%) | -$269.55M(-0.2%) |
| Dec 2024 | -$264.43M(-44.8%) | -$40.12M(-2.3%) | -$269.98M(-42.4%) |
| Sep 2024 | - | -$41.07M(-55.0%) | -$469.06M(-3.1%) |
| Jun 2024 | - | -$91.16M(-6.6%) | -$484.08M(-2.1%) |
| Mar 2024 | - | -$97.64M(-59.2%) | -$494.21M(+3.2%) |
| Dec 2023 | -$478.66M(+36.0%) | -$239.20M(+326.5%) | -$478.66M(+44.9%) |
| Sep 2023 | - | -$56.08M(-44.6%) | -$330.34M(-9.3%) |
| Jun 2023 | - | -$101.30M(+23.4%) | -$364.15M(+6.0%) |
| Mar 2023 | - | -$82.09M(-9.7%) | -$343.55M(-2.4%) |
| Dec 2022 | -$351.88M | -$90.87M(+1.1%) | -$351.90M(+2.2%) |
| Sep 2022 | - | -$89.90M(+11.4%) | -$344.49M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$80.69M(-10.8%) | -$335.73M(-0.3%) |
| Mar 2022 | - | -$90.44M(+8.4%) | -$336.85M(+5.0%) |
| Dec 2021 | -$320.75M(+57.1%) | -$83.47M(+2.9%) | -$320.75M(+6.6%) |
| Sep 2021 | - | -$81.13M(-0.8%) | -$301.00M(+6.8%) |
| Jun 2021 | - | -$81.82M(+10.1%) | -$281.97M(+14.4%) |
| Mar 2021 | - | -$74.33M(+16.7%) | -$246.50M(+20.7%) |
| Dec 2020 | -$204.22M(+45.6%) | -$63.72M(+2.6%) | -$204.22M(+45.4%) |
| Sep 2020 | - | -$62.09M(+34.0%) | -$140.50M(+79.2%) |
| Jun 2020 | - | -$46.35M(+44.6%) | -$78.41M(+144.6%) |
| Mar 2020 | - | -$32.06M | -$32.06M |
| Dec 2019 | -$140.30M | - | - |
FAQ
- What is ImmunityBio annual EBITDA?
- What is the all time high annual EBITDA for ImmunityBio?
- What is ImmunityBio annual EBITDA year-on-year change?
- What is ImmunityBio quarterly EBITDA?
- What is the all time high quarterly EBITDA for ImmunityBio?
- What is ImmunityBio quarterly EBITDA year-on-year change?
- What is ImmunityBio TTM EBITDA?
- What is the all time high TTM EBITDA for ImmunityBio?
- What is ImmunityBio TTM EBITDA year-on-year change?
What is ImmunityBio annual EBITDA?
The current annual EBITDA of IBRX is -$264.43M
What is the all time high annual EBITDA for ImmunityBio?
ImmunityBio all-time high annual EBITDA is -$140.30M
What is ImmunityBio annual EBITDA year-on-year change?
Over the past year, IBRX annual EBITDA has changed by +$214.23M (+44.76%)
What is ImmunityBio quarterly EBITDA?
The current quarterly EBITDA of IBRX is -$97.21M
What is the all time high quarterly EBITDA for ImmunityBio?
ImmunityBio all-time high quarterly EBITDA is -$32.06M
What is ImmunityBio quarterly EBITDA year-on-year change?
Over the past year, IBRX quarterly EBITDA has changed by +$431.00K (+0.44%)
What is ImmunityBio TTM EBITDA?
The current TTM EBITDA of IBRX is -$269.55M
What is the all time high TTM EBITDA for ImmunityBio?
ImmunityBio all-time high TTM EBITDA is -$32.06M
What is ImmunityBio TTM EBITDA year-on-year change?
Over the past year, IBRX TTM EBITDA has changed by +$224.66M (+45.46%)